Your browser doesn't support javascript.
loading
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis.
Zhou, Chengzhi; Yang, Yilin; Lin, Xinqing; Fang, Nianxin; Chen, Likun; Jiang, Juhong; Deng, Haiyi; Deng, Yu; Wan, Minghui; Qiu, Guihuan; Sun, Ni; Wu, Di; Long, Xiang; Zhong, Changhao; Xie, Xiaohong; Xie, Zhanhong; Liu, Ming; Ouyang, Ming; Qin, Yinyin; Petrella, Francesco; Fiorelli, Alfonso; Bravaccini, Sara; Kataoka, Yuki; Watanabe, Satoshi; Goto, Taichiro; Solli, Piergiorgio; Igai, Hitoshi; Saito, Yuichi; Tsoukalas, Nikolaos; Nakada, Takeo; Li, Shiyue; Chen, Rongchang.
Afiliação
  • Zhou C; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Yang Y; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Lin X; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Fang N; Affiliated Dongguan People's Hospital, Dongguan Institute of Respiratory and Critical Care Medicine, Southern Medical University, Dongguan, China.
  • Chen L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Jiang J; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Deng H; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Deng Y; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Wan M; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Qiu G; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Sun N; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Wu D; Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, China.
  • Long X; Department of Respiratory Disease, Peking University Shenzhen Hospital, Shenzhen, China.
  • Zhong C; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Xie X; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Xie Z; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Liu M; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Ouyang M; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Qin Y; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
  • Petrella F; Division of Thoracic Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
  • Fiorelli A; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Bravaccini S; Thoracic Surgery Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Kataoka Y; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Watanabe S; Department of Internal Medicine, Kyoto Min-Iren Asukai Hospital, Kyoto, Japan.
  • Goto T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Solli P; Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Yamanashi, Japan.
  • Igai H; Division of Thoracic Surgery & Lung Transplantation, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Saito Y; Department of General Thoracic Surgery, Japanese Red Cross Maebashi Hospital, Maebashi, Japan.
  • Tsoukalas N; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
  • Nakada T; Department of Oncology, 401 General Military Hospital, Athens, Greece.
  • Li S; Division of Thoracic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Chen R; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
Front Immunol ; 13: 935779, 2022.
Article em En | MEDLINE | ID: mdl-35967342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Proteína C-Reativa / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Proteína C-Reativa / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article